Overview
Dubowitz syndrome is a rare genetic disorder characterized by a distinctive facial appearance, growth restriction, microcephaly, and mild to moderate intellectual disability. First described by Dr. Victor Dubowitz in 1965, the condition is also sometimes referred to as intrauterine growth retardation with unusual facies. The characteristic facial features include a small, triangular face with a high or sloping forehead, sparse eyebrows and eyelashes, short palpebral fissures (narrow eye openings), broad or flat nasal bridge, and micrognathia (small jaw). Affected individuals typically present with prenatal and postnatal growth retardation, resulting in short stature. The syndrome affects multiple body systems. Skin manifestations, particularly eczema, are common and may be prominent in early childhood. Skeletal anomalies, feeding difficulties in infancy, and behavioral issues including hyperactivity and attention difficulties have been reported. Some patients may have immune system abnormalities, and there appears to be an increased susceptibility to certain malignancies, including leukemia and lymphoma, though this association is not fully established. Congenital anomalies of the genitourinary system, including cryptorchidism in males, and occasional cardiac and ocular abnormalities have also been described. The exact genetic cause of Dubowitz syndrome remains unknown, and the diagnosis is made clinically based on the constellation of characteristic features. The inheritance pattern is believed to be autosomal recessive based on reports of affected siblings and parental consanguinity in some families. There is no specific cure or targeted therapy for Dubowitz syndrome. Management is supportive and multidisciplinary, addressing individual symptoms such as eczema treatment, growth monitoring, developmental support and early intervention programs, and surveillance for potential malignancies. Regular follow-up with specialists in dermatology, endocrinology, and developmental pediatrics is recommended.
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Dubowitz syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Dubowitz syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Dubowitz syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Dubowitz syndrome.
Community
No community posts yet. Be the first to share your experience with Dubowitz syndrome.
Start the conversation →Latest news about Dubowitz syndrome
No recent news articles for Dubowitz syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Dubowitz syndrome
What is Dubowitz syndrome?
Dubowitz syndrome is a rare genetic disorder characterized by a distinctive facial appearance, growth restriction, microcephaly, and mild to moderate intellectual disability. First described by Dr. Victor Dubowitz in 1965, the condition is also sometimes referred to as intrauterine growth retardation with unusual facies. The characteristic facial features include a small, triangular face with a high or sloping forehead, sparse eyebrows and eyelashes, short palpebral fissures (narrow eye openings), broad or flat nasal bridge, and micrognathia (small jaw). Affected individuals typically present
How is Dubowitz syndrome inherited?
Dubowitz syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Dubowitz syndrome typically begin?
Typical onset of Dubowitz syndrome is neonatal. Age of onset can vary across affected individuals.